Metaraminol Bitartrate

Known as: Tartrate, Metaraminol, Metaraminol Bitartrate (1:1), Metaraminol Tartrate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1957-2016
01219572016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
INTRODUCTION Priapism is an uncommon disorder of involuntary prolonged erection beyond sexual excitement or desire. Herein, we… (More)
  • figure 1
Is this relevant?
1998
1998
The effects of metaraminol bitartrate on intraocular pressure (IOP) were studied in dogs anesthetized with halothane. Forty-five… (More)
Is this relevant?
1990
1990
A 30-year-old male with post-traumatic priapism for 7 days was treated successfully by metaraminol bitartrate injection into the… (More)
Is this relevant?
1980
1980
A high-performance liquid chromatographic (HPLC) procedure was developed for the determination of metaraminol bitartrate in the… (More)
Is this relevant?
1979
1979
Acute hypertension, induced either by intravenous injection of metaraminol bitartrate (Aramine), infusion of isotonic saline into… (More)
Is this relevant?
1978
1978
A fluorescence assay for metaraminol bitartrate injection has been developed which uses o-phthalaldehyde as a fluorogenic reagent… (More)
Is this relevant?
1977
1977
Acute hypertension in rats was produced by intravenous infusion of metaraminol bitartrate (Aramine). The permeability to… (More)
  • table 1
  • table 2
  • figure 3
  • figure 4
  • figure 8
Is this relevant?
1975
1975
The no-reflow phenomenon has been produced in the cerebral hemispheres of the gerbil by 30 minutes of bilateral carotid artery… (More)
  • table 1
  • table 2
Is this relevant?
1970
1970
A study was made on the effect of acute hypertension on the blood-brain barrier to proteins. The arterial blood pressure was… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1964
1964
Increasing doses of metaraminol bitartrate (Aramine) in a continuous intravenous infusion were used to support the blood pressure… (More)
Is this relevant?